Marine Andersson

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Pharmacist and PhD at Clinical Pharmacology, Department of Laboratory
Medicine. Main interests are drug interactions and I am deeply involved in
the content in the knowledge databases Janusmed Interactions and Risk
Profile.

Forskningsbeskrivning

Publications:
https://www.ncbi.nlm.nih.gov/pubmed/?term=andersson+marine

Artiklar

Article: PHARMACY. 2024;12(6):168
Potential Adverse Drug Events Identified with Decision Support Algorithms from Janusmed Risk Profile-A Retrospective Population-Based Study in a Swedish Region.
Hammar T; Jonsén E; Björneld O; Askfors Y; Andersson ML; Lincke A
Article: PHARMACEUTICS. 2024;16(3):303
Drug-Drug Interactions in Patients with Acute Respiratory Distress Syndrome
Bischof T; Schaller C; Buchtele N; Staudinger T; Ullrich R; Kraft F; Andersson ML; Jilma B; Schoergenhofer C
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2023;79(9):1261-1269
Medicines postpartum in Sweden and coverage in Janusmed Breastfeeding
Asplund AB; Skold PD; Lind LK; Cesta CE; Dahl ML; Jonsson EW; Andersson ML
Article: DRUGS & AGING. 2023;40(4):369-376
Pharmacological Risk Assessment Among Older Patients with Polypharmacy Using the Clinical Decision Support System Janusmed Risk Profile: A Cross-Sectional Register Study
Petersson L; Schoergenhofer C; Askfors Y; Justad H; Dahl M-L; Andersson MLL
Article: PHARMACY. 2021;9(1):23
Patients' Use and Perceptions of a Drug-Drug Interaction Database: A Survey of Janusmed Interactions
Justad H; Askfors Y; Shemeikka T; Andersson ML; Hammar T
Article: EXPERT REVIEW OF CLINICAL PHARMACOLOGY. 2020;13(9):925-934
Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet
Hoffmann M; Vander Stichele R; Bates DW; Bjorklund J; Alexander S; Andersson ML; Auraaen A; Bennie M; Dahl M-L; Eiermann B; Hackl W; Hammar T; Hjemdahl P; Koch S; Kunnamo I; Le Louet H; Panagiotis P; Raego L; Spedding M; Seidling HM; Demner-Fushman D; Gustafsson LL
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2019;75(10):1387-1392
The effect of simvastatin on warfarin anticoagulation: a Swedish register-based nationwide cohort study
Andersson ML; Mannheimer B; Lindh JD
Article: BMC GERIATRICS. 2019;19(1):164
Clinical relevance of alerts from a decision support system, PHARAO, for drug safety assessment in the older adults
Hedna K; Andersson ML; Gyllensten H; Hagg S; Bottiger Y
Article: PLOS ONE. 2019;14(4):e0215356
Is tramadol associated to bleeding peptic ulcer? A nationwide case-control study in hospitalized Swedish patients
Jarnbert-Pettersson H; Andersson M; Bilen K; Brostrom O; Lindh J; Mannheimer B
Article: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2018;122(5):512-516
High Prevalence of Drug-Drug Interactions in Primary Health Care is Caused by Prescriptions from other Healthcare Units
Andersson ML; Bottiger Y; Kockum H; Eiermann B
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2018;74(3):365-371
Development and pilot testing of PHARAO-a decision support system for pharmacological risk assessment in the elderly
Bottiger Y; Laine K; Korhonen T; Lahdesmaki J; Shemeikka T; Julander M; Edlert M; Andersson ML
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2017;15(3):446-453
The effect of amiodarone on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population
Holm J; Lindh JD; Andersson ML; Mannheimer B
Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2016;14(4):765-771
The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population
Mannheimer B; Andersson ML; Jarnbert-pettersson H; Lindh JD
Article: INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS. 2015;84(5):327-333
Evaluation of usage patterns and user perception of the drug-drug interaction database SFINX
Andersson ML; Bottiger Y; Bastholm-Rahmner P; Ovesjo M-L; Veg A; Eiermann B
Article: PLOS ONE. 2014;9(5):e97388
Adherence to Guidelines for Avoiding Drug Interactions Associated with Warfarin - A Nationwide Swedish Register Study
Lindh JD; Andersson ML; Mannheimer B
Article: JOURNAL OF CLINICAL PHARMACOLOGY. 2013;53(12):1322-1327
The Impact of Interacting Drugs on Dispensed Doses of Warfarin in the Swedish Population: A Novel Use of Population Based Drug Registers
Andersson ML; Lindh JD; Mannheimer B
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69:65-72
The continuing challenge of providing drug information services to diminish the knowledge-practice gap in medical practice
Alvan G; Andersson ML; Asplund AB; Bottiger Y; Elwin C-E; Gustafsson LL; Ohman B; Tornqvist E
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69(3):565-571
Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care
Andersson ML; Bottiger Y; Lindh JD; Wettermark B; Eiermann B
Article: PHARMACOGENOMICS. 2012;13(7):757-762
A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele
Andersson ML; Eliasson E; Lindh JD
Article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2011;72(1):153-156
Possible drug-drug interaction between quetiapine and lamotrigine - evidence from a Swedish TDM database
Andersson ML; Bjorkhem-Bergman L; Lindh JD
Article: DRUG METABOLISM AND DISPOSITION. 2011;39(5):933-937
Seasonal Variation in Blood Drug Concentrations and a Potential Relationship to Vitamin D
Lindh JD; Andersson ML; Eliasson E; Bjorkhem-Bergman L
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2009;65(6):627-633
SFINX-a drug-drug interaction database designed for clinical decision support systems
Bottiger Y; Laine K; Andersson ML; Korhonen T; Molin B; Ovesjo M-L; Tirkkonen T; Rane A; Gustafsson LL; Eiermann B
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2009;65(4):365-375
Influence of CYP2C9 genotype on warfarin dose requirements-a systematic review and meta-analysis
Lindh JD; Holm L; Andersson ML; Rane A
Article: LAKARTIDNINGEN. 2006;103(14):1112-1114
[Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time].
Odar-Cederlöf I; Hjelmström P; Jersenius I; Andersson M; Rasmanis G; Bergman U
Visa fler

Alla övriga publikationer

Doctoral thesis: 2014
Drug-drug interactions : from knowledge base to clinical impact
Andersson M
Review: DRUGS. 2013;73(6):533-543
Cytochrome P450-Mediated Changes in Oxycodone Pharmacokinetics/Pharmacodynamics and Their Clinical Implications
Lofdal KCS; Andersson ML; Gustafsson LL
Letter: PHARMACOGENOMICS. 2012;13(14):1561-1562
Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatin: author reply
Andersson ML; Eliasson E; Lindh JD

Anställningar

Anknuten till Undervisning/Handledning, Laboratoriemedicin, Karolinska Institutet, 2023-2026

Examina och utbildning

Docent, farmakologi och toxikologi, Karolinska Institutet, 2024
Medicine Doktorsexamen, Institutionen för laboratoriemedicin, Karolinska Institutet, 2014

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI